Home Page ::: Current Pharmaceutical Biotechnology

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)

Volume 16, 12 Issues, 2015

Download PDF Flyer

Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 112th of 254 in

    Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online


Zeno Foldes-Papp

Visiting Professor of Medical Biochemistry
HELIOS Clinical Center of Emergency Medicine
Department for Internal Medicine
Alte-Koelner-Strasse 9
D-51688 Koeln-Wipperfuerth

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.95
5 - Year: 2.558
Browse Contents
Select Volume:

Select Issue:

Select Article:


"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."

Robert Huber
Nobel Laureate

Forthcoming Special Issue(s)

CURRENT TOPICS IN PHARMACEUTICAL BIOTECHNOLOGY Special Issue in Memory of Prof. Dr. Luis Eduardo Diaz

Guest Editor(s): Dr. Martín F. Desimone
Tentative Publication Date: December, 2015
Submit Abstract via Email Download Description
Published Special Issue(s)

Antimicrobial Strategies Based on Natural Products: Recent Progress in Bio and Nanotechnology

Guest Editor(s): Alina Maria HOLBAN, Alexandru Mihai GRUMEZESCU
Download Description
Authors' Comments
I would like to express to you and the whole staff of the Current Pharmaceutical Biotechnology journal my gratitude for the excellent help and support during submission, review and publication process. Thank you so much.

Professor. Edward Ratovitski
(Head and Neck Cancer Research, Johns Hopkins University School of Medicine, Baltimore, USA)

Has contributed: ΔNp63α-responsive microRNAs modulate the expression of metabolic enzymes in squamous cell carcinoma cells

Current Pharmaceutical Biotechnology


Volume 16


Number 12

Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:


Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science